Sun Pharmaceutical Industries share price closes at ₹1,846.40; drops 1.20%
Varda Khade
- 0 min read
Last Updated: 22nd September 2026 - 05:42 pm
Key Takeaways:
- Sun Pharmaceutical Industries fell ₹22.50 or 1.20% to ₹1,846.40, ending just ₹4.40 above its September 22 low.
- The stock closed below its 50-day and 100-day DMAs but remained ₹21.50 above its 200-day DMA.
- Three-month, six-month and one-year returns were positive, while the one-month reading stood at -2.94%.
Sun Pharmaceutical Industries share price finished September 22 at ₹1,846.40, down ₹22.50 or 1.20% from the previous close of ₹1,869. The stock opened at ₹1,869 and advanced to ₹1,876. It then moved down to ₹1,842 and closed just ₹4.40 above that session low.
The high-low difference was ₹34. Sun Pharma ended ₹29.60 below the day's peak and ₹22.60 below the opening price. Volume reached 1,109,486 shares. Market capitalisation stood at approximately ₹443,013 crore.
Its moving-average position was split. The 50-day DMA stood at ₹1,895, leaving the close ₹48.60 lower. The 100-day DMA was ₹1,872.10, putting the final price ₹25.70 below it. The 200-day DMA, however, was lower at ₹1,824.90, so the September 22 close remained ₹21.50 above that measure.
The stock's 52-week range extended from ₹1,548 to ₹2,047. At ₹1,846.40, Sun Pharma was ₹298.40 above the annual low and ₹200.60 below the high.
Performance readings were positive over most of the longer periods. The one-month return was -2.94%, while the three-month figure stood at 0.44%. Six-month performance was 3.90%, and the one-year return reached 11.50%. September 22 itself ended 1.20% lower, with the final price near the bottom of the daily range. Despite that decline, the close remained above the 200-day DMA while falling below the 50-day and 100-day averages.
Frequently Asked Questions
How close did Sun Pharma finish to its daily low?
Was Sun Pharma above its 200-day DMA?
What were Sun Pharma's recent returns?
- Flat ₹20 Brokerage
- Next-gen Trading
- Advanced Charting
- Actionable Ideas
Trending on 5paisa
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.